Kudos to Our Client for Vaccine Development Work

Gaithersburg-based Emergent, a DataLink client, recently won a contract with the U.S. government worth $628 million to manufacture novel coronavirus vaccines. It’s also developing plasma-derived therapies targeting COVID-19.

The company will manufacture vaccines, assisting government efforts to fast-track the vaccine. Emergent has long worked with the federal health agency, BARTA, the Biomedical Advanced Research and Development Authority. Emergent is also collaborating on COVID-19 vaccines with Johnson & Johnson, Novavax, and Vaxart.

As Emergent’s South Baltimore drug product manufacturing facility was being expanded and retro-fitted to expand its fill/finish production and warehouse space, DataLink’s network infrastructure team rebuilt, organized, tagged and certified the cable management system and structured cabling throughout the 45,000 sq. ft facility.

Need support with your mission critical networks? Our experienced IT experts design, install and support technology solutions that will keep your business and your people connected, safe and productive.